RSS

libido

Catalent Pharma Solutions has announced a commercial supply agreement with Palatin Technologies to globally launch Palatin’s bremelanotide pen injector product, which is used to treat female sexual dysfunction (FSD) more

Jul 1, 2016 11:31 AM News